Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 19Unknown 12Terminated 9Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3783INDUSTRY 716OTHER_GOV 156NETWORK 32NIH 28FED 8UNKNOWN 2INDIV 1

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

blinatumomab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × INDIV × Interventional × Clear all
NCT06836973 2025-03-25

Blinatumomab for Treatment of Refractory Myasthenia Gravis

Da, Yuwei, M.D.

Phase 2/3 Not yet recruiting
2 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡